Leicester Royal Infirmary, University Hospitals of Leicester NHS Trust

Site:	Leicester Royal Infirmary, University Hospitals of Leicester NHS Trust
Address:
City:	Leicester
State:
Zip:
Country:	UK

Phase	Trial	Trial Status	Site Status	Drug	NCT#
3	Study of Regorafenib as a 3rd-line or Greater Treatment for Gastrointestinal Stromal Tumors (GIST) (GRID)	Ongoing, but not recruiting	Closed	Regorafenib (BAY 73-4506)	NCT01271712